1. Home
  2. Directory
  3. Colorado
  4. Fort Collins
  5. Orthopaedic Surgery
  6. NPI Profile
  7. Prescriptions 1194782995

WESLEY P JACKSON MD
Prescription History 1194782995
Orthopaedic Surgery - Foot and Ankle Surgery in Fort Collins, CO


Quality Rating: 73.87 out of 100 score

NPI Status: Active since April 27, 2006

Contact Information

2500 E PROSPECT RD
FORT COLLINS, CO
ZIP 80525
Phone: (970) 493-0112

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for WESLEY P JACKSON MD, an active Foot and Ankle Surgery specialist practicing in Fort Collins, CO. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 169 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydrocodone-Acetaminophen, which accounts for 107 claims alone.

Medication Index

C
G
H
M
X
No matching medications currently found on file.

Cephalexin

Generic Formulation: CephalexinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 137
CO State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.9
Peer Average Days Supply297
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $208.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.96

State Avg Cost Per Claim

$10.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Gabapentin

Generic Formulation: GabapentinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 18.0
Days Supply 471
CO State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills114.5
Peer Average Days Supply3,349
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.3% less volume than the regional standard for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $48.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.03

State Avg Cost Per Claim

$25.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 107
30-Day Fills 107.0
Days Supply 368
CO State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills46.4
Peer Average Days Supply879
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 132.6% higher than the standard regional baseline profile for CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $748.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.00

State Avg Cost Per Claim

$19.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 18.0
Days Supply 530
CO State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills64.7
Peer Average Days Supply1,899
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.7% less volume than the regional standard for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $100.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.39

State Avg Cost Per Claim

$8.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Xarelto

Generic Formulation: RivaroxabanSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 298
CO State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills63.1
Peer Average Days Supply1,771
Conservative Utilization

This provider writes prescriptions for this formulation 45.7% less frequently than the standard regional baseline metric for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,832.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$306.96

State Avg Cost Per Claim

$905.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Therapeutic Applications

Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like WESLEY P JACKSON MD provides transparency into local medical care patterns within Fort Collins, CO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Foot and Ankle Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.